Pellegatta S - Search Results

1

Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing.

Riccadonna C, Yacoub Maroun C, Vuillefroy de Silly R, Boehler M, Calvo Tardón M, Jueliger S, Taverna P, Barba L, Marinari E, Pellegatta S, Bassoy EY, Martinvalet D, Dietrich PY, Walker PR. Riccadonna C, et al. Among authors: pellegatta s. PLoS One. 2016 Aug 31;11(8):e0162105. doi: 10.1371/journal.pone.0162105. eCollection 2016. PLoS One. 2016. PMID: 27579489 Free PMC article.

2

Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas.

Pellegatta S, Poliani PL, Corno D, Menghi F, Ghielmetti F, Suarez-Merino B, Caldera V, Nava S, Ravanini M, Facchetti F, Bruzzone MG, Finocchiaro G. Pellegatta S, et al. Cancer Res. 2006 Nov 1;66(21):10247-52. doi: 10.1158/0008-5472.CAN-06-2048. Cancer Res. 2006. PMID: 17079441 Free article.

3

Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.

Orzan F, Pellegatta S, Poliani PL, Pisati F, Caldera V, Menghi F, Kapetis D, Marras C, Schiffer D, Finocchiaro G. Orzan F, et al. Among authors: pellegatta s. Neuropathol Appl Neurobiol. 2011 Jun;37(4):381-94. doi: 10.1111/j.1365-2990.2010.01132.x. Neuropathol Appl Neurobiol. 2011. PMID: 20946108

4

ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells.

Bassoy EY, Kasahara A, Chiusolo V, Jacquemin G, Boydell E, Zamorano S, Riccadonna C, Pellegatta S, Hulo N, Dutoit V, Derouazi M, Dietrich PY, Walker PR, Martinvalet D. Bassoy EY, et al. Among authors: pellegatta s. EMBO J. 2017 Jun 1;36(11):1493-1512. doi: 10.15252/embj.201695429. Epub 2017 Mar 10. EMBO J. 2017. PMID: 28283580 Free PMC article.

5

Cell therapies in neuro-oncology.

Pellegatta S, Finocchiaro G. Pellegatta S, et al. Neurol Sci. 2005 May;26 Suppl 1:S43-5. doi: 10.1007/s10072-005-0405-x. Neurol Sci. 2005. PMID: 15883693

6

Dendritic cell vaccines for cancer stem cells.

Pellegatta S, Finocchiaro G. Pellegatta S, et al. Methods Mol Biol. 2009;568:233-47. doi: 10.1007/978-1-59745-280-9_15. Methods Mol Biol. 2009. PMID: 19582431

7

Intra-tumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironment.

Pellegatta S, Poliani PL, Stucchi E, Corno D, Colombo CA, Orzan F, Ravanini M, Finocchiaro G. Pellegatta S, et al. Neuro Oncol. 2010 Apr;12(4):377-88. doi: 10.1093/neuonc/nop024. Epub 2010 Jan 6. Neuro Oncol. 2010. PMID: 20308315 Free PMC article.

8

A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment.

Cantini G, Pisati F, Mastropietro A, Frattini V, Iwakura Y, Finocchiaro G, Pellegatta S. Cantini G, et al. Among authors: pellegatta s. Cancer Immunol Immunother. 2011 Dec;60(12):1739-50. doi: 10.1007/s00262-011-1069-4. Epub 2011 Jul 21. Cancer Immunol Immunother. 2011. PMID: 21779877 Free PMC article.

9

Immunotherapy for glioma: getting closer to the clinical arena?

Finocchiaro G, Pellegatta S. Finocchiaro G, et al. Among authors: pellegatta s. Curr Opin Neurol. 2011 Dec;24(6):641-7. doi: 10.1097/WCO.0b013e32834cbb17. Curr Opin Neurol. 2011. PMID: 22027543 Review.

10

Brain cancer immunoediting: novel examples provided by immunotherapy of malignant gliomas.

Pellegatta S, Cuppini L, Finocchiaro G. Pellegatta S, et al. Expert Rev Anticancer Ther. 2011 Nov;11(11):1759-74. doi: 10.1586/era.11.102. Expert Rev Anticancer Ther. 2011. PMID: 22050025 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters